Sarah Fakih

Investor Relations Contact at EVOTEC SE

Health Technology

Consumer Services

Commercial Services

Profile

Sarah Fakih currently works at Evotec SE, as Head-Global Communications & Investor Relations from 2026.
Dr. Fakih also formerly worked at QIAGEN NV, as Director-Investor Relations, MorphoSys AG, as Vice President & Head-Corporate Communications, and CureVac NV, as Vice President-Investor Relations & Communications.
Dr. Fakih received her doctorate degree from the University of Münster and Masters Business Admin degree from Julius-Maximilians-Universität Würzburg.

Sarah Fakih active positions

Companies	Position	Start
EVOTEC SE	Investor Relations Contact	2025-12-31

All active positions of Sarah Fakih

Former positions of Sarah Fakih

Companies	Position	End
MORPHOSYS AG	Public Communications Contact	-
CUREVAC	Investor Relations Contact	-
QIAGEN N.V.	Public Communications Contact	-

See the detail of Sarah Fakih's experience

Education of Sarah Fakih

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sarah Fakih's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
QIAGEN NV QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations	Health Technology
Evotec SE Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services	Commercial Services
MorphoSys AG MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services	Health Technology
University of Münster University of Münster Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Julius-Maximilians-Universität Würzburg Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CureVac NV CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies	Health Technology